Among the multiple clonal abnormalities identified in the bone marrow, cytogenetic studies revealed a partial deletion of PDGFRβ. The PDGFRβ rearrangements seen in MDS/MPN are rare but delineate a distinct type of myeloid neoplasm with characteristic clinicopathologic features. The gene discussed is PDGFRB; the disease is myelodysplastic syndrome.